PRMT5-dependent p53 escape in tumorigenesis

Yan Li1, J Alan Diehl1

  • 1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.

Oncoscience
|October 2, 2015
PubMed

Insights

Protein arginine methyltransferase 5 (PRMT5) promotes cancer cell survival by modifying wild-type p53. This mechanism helps tumors evade apoptosis, even when p53 is functional.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Mutations in p53 signaling are common in human cancers.
  • The mechanisms enabling cancer cells with wild-type p53 to bypass its tumor-suppressive functions are not fully understood.

Purpose of the Study:

  • To investigate the role of PRMT5 in the evasion of wild-type p53 tumor suppression.
  • To elucidate how PRMT5 contributes to cancer cell survival and apoptosis evasion.

Main Methods:

  • Analysis of PRMT5 expression in human cancers.
  • Investigating the interaction between PRMT5, cyclin D1, and p53.
  • Assessing the effect of PRMT5 on p53 arginine methylation.
  • Evaluating the impact of PRMT5-mediated p53 modification on apoptosis.

Main Results:

  • PRMT5 is frequently elevated in human cancers.
  • PRMT5 cooperates with oncogenic cyclin D1.
  • PRMT5 mediates arginine methylation of wild-type p53.
  • This modification promotes the bypass of wild-type p53 function, leading to apoptosis evasion.

Conclusions:

  • PRMT5 plays a critical role in enabling cancer cells with functional p53 to evade apoptosis.
  • Targeting PRMT5 may offer a therapeutic strategy for cancers that retain wild-type p53.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K